Novo Nordisk (NVO) ROE US GAAP (year values) |
|||||||||
2021 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROE, % | ? | 67.5% | 67.5% | 66.5% | 66.5% | 78.5% | 55.9% | ||
Changes by years, y/y, % | +1pp | 0pp | -1pp | 0pp | +12pp | +1.1% |
Novo Nordisk. ROE, %
Novo Nordisk. ROE, changes, pp
Novo Nordisk (NVO) ROE US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
ROE, % | ? | 81.0% | 78.5% | 90.3% | 79.9% | 74.6% | 55.9% | |
Changes by years, y/y, % | +12pp | +12pp | +65pp | +13pp | -6pp | |||
Changes by quarters, q/q, % | +14pp | -2pp | +12pp | -10pp | -5pp |